Dual orexin receptor antagonists (DORAs) prolong total sleep time (TST) and enhance sleep efficiency (SE) without impairing respiratory function among patients with obstructive sleep apnea (OSA).
There are however questions that should be clarified, especially the conflict between three identified parallel pathways and the observed complete inhibition of the constriction by blockage of the NPY ...
Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.